NCT01368341View on ClinicalTrials.gov

Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice

PHASE4CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2014

Conditions
Erythema MigransErythema Chronicum MigransBorreliosisLyme DiseaseEarly Lyme Disease
Interventions
DRUG

Doxycycline

1 tablet, 100 mg, b.i.d. 14 days

DRUG

Phenoxymethylpenicillin

Tablet 650 mg, 2 tablets, t.i.d., 14 days

DRUG

Amoxicillin

Capsula, 500 mg, t.i.d., 14 days

Trial Locations (1)

0318

Antibiotic Centre for Primary Care, University of Oslo, Oslo

All Listed Sponsors
collaborator

Norwegian Institute of Public Health

OTHER_GOV

collaborator

Sorlandet Hospital HF

OTHER_GOV

collaborator

Norwegian University of Life Sciences

OTHER

lead

Morten Lindbaek

OTHER

NCT01368341 - Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice | Biotech Hunter | Biotech Hunter